Eli Lilly and (LLY)
NYSE: LLY
· Real-Time Price · USD
725.90
1.36 (0.19%)
At close: Sep 29, 2025, 3:06 PM
Immunology Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.26B | 167.6M | +15.40% |
| Mar 31, 2025 | 1.09B | -97.7M | -8.24% |
| Sep 30, 2024 | 1.19B | 103.3M | +9.54% |
| Jun 30, 2024 | 1.08B | 529.9M | +95.91% |
| Mar 31, 2024 | 552.5M | -1.22B | -68.75% |
| Sep 30, 2023 | 1.77B | 1.38B | +356.64% |
| Jun 30, 2023 | 387.2M | 26.7M | +7.41% |
| Mar 31, 2023 | 360.5M | -73.3M | -16.90% |
| Sep 30, 2022 | 433.8M | -25.7M | -5.59% |
| Jun 30, 2022 | 459.5M | -12.4M | -2.63% |
| Mar 31, 2022 | 471.9M | -54.8M | -10.40% |
| Sep 30, 2021 | 526.7M | -70.4M | -11.79% |
| Jun 30, 2021 | 597.1M | 58.2M | +10.80% |
| Mar 31, 2021 | 538.9M | 68.2M | +14.49% |
| Sep 30, 2020 | 470.7M | 48.2M | +11.41% |
| Jun 30, 2020 | 422.5M | -41M | -8.85% |
| Mar 31, 2020 | 463.5M | 36.8M | +8.62% |
| Sep 30, 2019 | 426.7M | -26M | -5.74% |
| Jun 30, 2019 | 452.7M | 59.6M | +15.16% |
| Mar 31, 2019 | 393.1M | -328.6M | -45.53% |
| Dec 31, 2015 | 721.7M | -2.8M | -0.39% |
| Sep 30, 2015 | 724.5M | -39.4M | -5.16% |
| Jun 30, 2015 | 763.9M | 38.6M | +5.32% |
| Mar 31, 2015 | 725.3M | -143.2M | -16.49% |
| Dec 31, 2014 | 868.5M | -13.9M | -1.58% |
| Sep 30, 2014 | 882.4M | 24M | +2.80% |
| Jun 30, 2014 | 858.4M | 94.1M | +12.31% |
| Mar 31, 2014 | 764.3M | -110.1M | -12.59% |
| Dec 31, 2013 | 874.4M | 52.6M | +6.40% |
| Sep 30, 2013 | 821.8M | 13.7M | +1.70% |
| Jun 30, 2013 | 808.1M | 43.9M | +5.74% |
| Mar 31, 2013 | 764.2M | -75M | -8.94% |
| Dec 31, 2012 | 839.2M | 47.5M | +6.00% |
| Sep 30, 2012 | 791.7M | -55.1M | -6.51% |
| Jun 30, 2012 | 846.8M | 42.9M | +5.34% |
| Mar 31, 2012 | 803.9M | -13.9M | -1.70% |
| Sep 30, 2011 | 817.8M | -8M | -0.97% |
| Jun 30, 2011 | 825.8M | -14.1M | -1.68% |
| Mar 31, 2011 | 839.9M | -140.4M | -14.32% |
| Sep 30, 2010 | 980.3M | n/a | n/a |